Introduction. Type 2 diabetes mellitus (T2DM) in the elderly is characterized by a high prevalence of geriatric syndromes (GS) and polypharmacy, which increases patient vulnerability. Therapy with sulfonylureas (SU) is associated with an increased risk of hypoglycemia, especially in older adults. Finding approaches to comprehensive outpatient support for these patients is relevant. Aim. To analyze the initial geriatric and clinical-metabolic status of a cohort of elderly patients with T2DM to substantiate an outpatient monitoring program aimed at correcting GS and optimizing therapy. Mat erials and methods. A cross-sectional study was conducted involving 40 T2DM patients (30 women, 10 men) aged ≥ 65 years receiving SU. All underwent comprehensive geriatric assessment (SPPB, dynamometry, Barthel and Lawton scales, MMSE, MoCA, GDS-15, Insomnia Severity Index), evaluation of clinical-metabolic parameters, fall risk, polypharmacy, and social activity. Results. The mean age was 72.3 ± 4.6 years, T2DM duration was 12 [8.0; 17.5] years, and HbA1c was 7.4 ± 1.1%. Polypharmacy was detected in 90% of patients, with a median number of drugs of 7 [5; 8]. Hypoglycemia history was reported by 45%, and 50% were unaware of its management. Prefrailty/frailty by SPPB was found in 40%, low muscle strength in 30%, falls in 30%, and home fall risk factors in 95%. Mild cognitive impairment by MoCA was detected in 42.5% (by MMSE – in 25%). Social activity was preserved in most (80%). Conclusions. A high prevalence of GS, polypharmacy, and poor awareness of hypoglycemia was revealed in elderly T2DM patients on SU therapy. The results justify the need to develop a comprehensive outpatient support program focused on deprescribing, fall prevention, and cognitive impairment management.